Latest Markets Business BEEPS Earnings Personal Finance

Sun Pharma Board Declares Dividend Of Rs 5.5 Per Share — Check Record Date

The dividend will be paid on Aug. 8 after its approval at the annual general meeting.

Prajwal Jayaraj

Sun Pharmaceutical Industries Ltd. declared a final dividend of Rs 5.5 with the face value of Re 1 for fiscal 2025, according to an exchange filing from the company (Photo Source: Sun Pharmaceuticals Industries/ Facebook)

Sun Pharmaceutical Industries Ltd. declared a final dividend of Rs 5.5 apiece with the face value of Re 1 for fiscal 2025, according to an exchange filing on Thursday.

The dividend is subject to approval from shareholders at the upcoming annual general meeting. The record date for the purpose of determining the members eligible to receive the dividend will be July 7, 2025.

The dividend will be paid on Aug. 8 post approval at the AGM.

Also Read: Q4 Results: Ramco Cements Profit Down; Grasim Industries Loss Narrows; Container Corp Profit Steady

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
WRITTEN BY
Prajwal Jayaraj
Prajwal Jayaraj covers business news for NDTV Profit. He holds a postgradua... more
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google
Beeps Img

Senco Gold Q2 Update: Revenue Rises 7%; Diamond Sales Jump 12%

  • chevron-double-right Senco Gold reported a 6.5% revenue rise in the second quarter despite high gold prices and duty cuts
  • chevron-double-right First half revenue growth was 17.8% with retail business increasing by 16% and same-store sales up 7.5%
  • chevron-double-right The company has achieved 12% growth in diamond jewellery sales extending the momentum in the second quarter
More Beeps chevron-right

RECOMMENDED FOR YOU

Stock Picks Today: Sun Pharma, KPIT Tech, BHEL, Nazara Tech, CMS Info, Godrej Properties On Brokerages' Radar
timelogo Oct 01, 2025
Trump Tariffs: Bitter Pill For Sun Pharma? Goldman Sachs Explains Why The Drugmaker May Face Pressure
timelogo Sep 29, 2025
US Tariffs: Only Sun Pharma Exposed To Some Headline Risk, But With Limited Earnings Impact
timelogo Sep 28, 2025
Sun Pharma Is Well Poised To Sustain Growth In Focus Segments, Says Motilal Oswal Maintaining 'Buy'
timelogo Sep 24, 2025

POPULAR

1
India's Finternet To Go Live In 2026, Using AI And Tokenisation: Nandan Nilekani
2
Tata Capital IPO: Check Day Three GMP, Subscription Status And More
3
ESOP Scam 'Architect': ED Slaps Chargesheet Against Former Religare Executive Chairperson
4
Anantam Highways Trust IPO Subscribed 33% On Day 2, Check GMP And Other Details
5
Rubicon Research Raises Rs 619 Crore From Anchor Investors Ahead Of IPO
Google Badge